Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.
Open Access
- 1 June 1996
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 97 (11) , 2440-2451
- https://doi.org/10.1172/jci118691
Abstract
The primary hypothesis of this report is that the formation and subsequent removal of fibrin in specific tissues during pathologic processes reflects temporal changes in the local expression of key procoagulant and fibrinolytic genes. To begin to test this hypothesis, we have used quantitative PCR assays and in situ hybridization analysis to examine the effects of endotoxin on the expression of specific genes in murine tissues, and to relate these changes to fibrin deposition/dissolution using immunohistochemical approaches. Endotoxin caused large increases in plasminogen activator inhibitor-1 mRNA and modest increases in tissue factor mRNA in most tissues examined. However, fibrin was only detected in the kidneys and adrenals of endotoxin-treated mice, and it was transient. Unexpectedly, changes in urokinase-type plasminogen activator mRNA but not tissue-type plasminogen activator mRNA correlated with fibrin deposition/dissolution in these tissues. Pretreatment of mice with the fibrinolytic inhibitor epsilon-aminocaproic acid before endotoxin increased both the number of fibrin-positive tissues and the duration of fibrin deposition in the kidneys and adrenals. These results suggest that the absence of fibrin in some tissues reflects ongoing local fibrinolysis, and that increases in plasminogen activator inhibitory and tissue fac- tor gene expression and decreases in urokinase-type plasminogen activator expression are necessary for tissue-specific fibrin deposition. Changes in tissue-type plasminogen activator gene expression do not appear to be essential for fibrin deposition/dissolution in this murine model of sepsis.Keywords
This publication has 51 references indexed in Scilit:
- Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.Journal of Clinical Investigation, 1996
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994
- Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.Journal of Clinical Investigation, 1993
- Structure of the murine tissue factor gene. Chromosome location and conservation of regulatory elements in the promoter.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouseEuropean Journal of Immunology, 1990
- Promotion and Subsequent Inhibition of Plasminogen Activation after Administration of Intravenous Endotoxin to Normal SubjectsNew England Journal of Medicine, 1989
- Tissue plasminogen activator mRNA in murine tissuesFEBS Letters, 1988
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Human endothelial cells contain one type of plasminogen activatorFEBS Letters, 1984
- Binding of human factor VII and VIIa to monocytes.Journal of Clinical Investigation, 1982